Delivery Order SPE2DB22D3016-SPE2DB24FAEJ5

Award Date 11/29/23
Potential Completion Date 11/30/23
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 1 gram sucralfate tablets, a medication used to treat stomach and duodenal ulcers, with a ceiling value of $2,193.65 and a period of performance through January 6, 2025. The contract is not designated with a set-aside requirement, indicating open competition. It is associated with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,350.69 Firm Fixed Price Delivery Order contract is for the provision of 90-count bottles of 1 gram Sucralfate tablets, a medication used to treat stomach and duodenal ulcers. The contract has an ultimate completion date of July 24, 2024 and was awarded on July 23, 2024. There was no set-aside designation,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of sucralfate 1 gram tablets. The contract has a firm fixed price and a ceiling value of $9,144.83. The period of performance extends to June 13, 2025. This contract is not set aside and is an open competition award. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,339.02, is for the delivery of 4,563,250,149 units of Sucralfate 1 GM Tablet 90S, a medication used to treat certain stomach and esophagus problems. This is a firm fixed-price delivery order contract with a period of performance through January 8, 2024. The contract is not designated as a...
This is a delivery order federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $24,503.59 firm fixed-price contract is for the delivery of 4,563,755,373 units of 1 gram sucralfate tablets, with a period of performance through February 26, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 420 ml bottles of 1 gram/10 ml Sucralfate suspension, a medication used to treat peptic ulcers. The contract has a firm fixed price of $1,308.52 and a period of performance through May 5, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp...
This is a delivery order from the Defense Logistics Agency (DLA) Troop Support Medical awarded to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract is for the supply of sucralfate 1 gram tablets, a pharmaceutical product used to treat digestive disorders. The delivery order has a ceiling value of $1,531.92 and is a firm fixed-price contract. The ultimate completion date for this order is September 26, 2024. Amerisourcebergen is a major supplier of pharmaceutical...
This federal contract award, SPE2DB22D2006|SPE2DB24FW0LU, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 90-count bottles of 1 gram Sucralfate tablets, a medication used to treat ulcers. The contract has a firm fixed price, a ceiling value of $40,792.77, and an ultimate completion date of May 21, 2024. This award is not designated as a set-aside contract....
This federal contract award, valued at $6,470.98, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, designated as a Delivery Order under an Indefinite Delivery Contract (IDC), covers the supply of 4,566,760,172 units of Sucralfate 1 GM Tablet 90S, a pharmaceutical product. The contract has an ultimate completion date of December 19, 2024. This award is part of Amerisourcebergen's...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Sucralfate 1 GM Tablet 500s. The contract has a ceiling value of $1,063.68 and a completion date of November 30, 2023. The contract is a firm fixed-price, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB24FAEJ5
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,927.25 firm fixed-price contract is for the supply of 90-count bottles of 1 gram sucralfate tablets, a medication used to treat certain stomach and duodenal ulcers.

The award is part of AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition.

Generated 5/12/25, 10:10 AM